TELEMS: Feasibility of Remote Patient Visits in MS

Medical University of Vienna45 enrolled

Overview

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Multiple Sclerosis

Interventions

EDSSOTHER

Neurological Exam - EDSS (Expanded Disability Status Scale)

Discussion of symptoms, Patient reported outcome (MSIS)OTHER

Patients will be asked about their wellbeing

Eligibility

Sex: ALLMin age: 16 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * confirmed diagnosis of any type of MS * own a phone/smartphone/computer * informed consent Exclusion Criteria: * language barriers

Locations (1)

Medical University of Vienna

Vienna, Austria

Outcomes

Primary Outcomes

TMPQ

Telemedicine Perception questionnaire (17-85, higher scores are better)

Time frame: 1 week after intervention

Secondary Outcomes

PPSM

Patient and Physician Satisfaction with monitoring (6-30, higher scores are better)

Time frame: 1 week after intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.